Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yara Abdou

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Scientific Reports|August 4, 2022
Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancerYara Abdou, Medhavi Gupta, Mariko Asaoka, et al.
Cancer Journal (Sudbury, Mass.)|November 14, 2023
From Race to Racism and Disparities to Equity: An Actionable Biopsychosocial Approach to Breast Cancer OutcomesKatherine Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, et al.
Frontiers in Immunology|May 28, 2024
Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studiesSiena M Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
NPJ Breast Cancer|November 9, 2022
Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitorsYara Abdou, Atta Goudarzi, Jia Xin Yu, et al.
NPJ Breast Cancer|August 16, 2025
Bridging the gap: ctDNA, genomics, and equity in breast cancer careJulia Aronson, Manasa Bhatta, Lisa A Carey, et al.
JAMA Oncology|April 3, 2025
Prognostic and Predictive Insights From Genomic Assays for Breast Cancer in Diverse Populations: A ReviewYara Abdou, Olga Kantor, Jennifer Racz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2026
Pertuzumab and Pathological Complete Response in Early HER2+ Breast Cancer: A Systematic Review and Meta-analysis of Real-World StudiesSilvio Matsas, Julita Zembala, Anderson Ruiz Simões, et al.
Oncology and Therapy|November 22, 2024
Cost-Utility Analysis of Multigene Assays to Guide Treatment Decisions for Node-Negative Early Breast CancerVladislav Berdunov, Gebra Cuyún-Carter, Yaneth Gil-Rojas, et al.
Journal of Medical Economics|March 11, 2024
Value of next generation sequencing (NGS) testing in advanced cancer patientsJesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, et al.
Therapeutic Advances in Medical Oncology|November 3, 2025
Prognostic utility of inflammatory indices and circulating nucleic acids for neoadjuvant chemotherapy outcomes in breast cancer: a systematic reviewSilvio Matsas, Anderson Ruiz Simões, Luiza Giuliani Schmitt, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Scientific Reports|August 4, 2022
Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancerYara Abdou, Medhavi Gupta, Mariko Asaoka, et al.
Cancer Journal (Sudbury, Mass.)|November 14, 2023
From Race to Racism and Disparities to Equity: An Actionable Biopsychosocial Approach to Breast Cancer OutcomesKatherine Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, et al.
Frontiers in Immunology|May 28, 2024
Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studiesSiena M Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
NPJ Breast Cancer|November 9, 2022
Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitorsYara Abdou, Atta Goudarzi, Jia Xin Yu, et al.
NPJ Breast Cancer|August 16, 2025
Bridging the gap: ctDNA, genomics, and equity in breast cancer careJulia Aronson, Manasa Bhatta, Lisa A Carey, et al.
JAMA Oncology|April 3, 2025
Prognostic and Predictive Insights From Genomic Assays for Breast Cancer in Diverse Populations: A ReviewYara Abdou, Olga Kantor, Jennifer Racz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2026
Pertuzumab and Pathological Complete Response in Early HER2+ Breast Cancer: A Systematic Review and Meta-analysis of Real-World StudiesSilvio Matsas, Julita Zembala, Anderson Ruiz Simões, et al.
Oncology and Therapy|November 22, 2024
Cost-Utility Analysis of Multigene Assays to Guide Treatment Decisions for Node-Negative Early Breast CancerVladislav Berdunov, Gebra Cuyún-Carter, Yaneth Gil-Rojas, et al.
Journal of Medical Economics|March 11, 2024
Value of next generation sequencing (NGS) testing in advanced cancer patientsJesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, et al.
Therapeutic Advances in Medical Oncology|November 3, 2025
Prognostic utility of inflammatory indices and circulating nucleic acids for neoadjuvant chemotherapy outcomes in breast cancer: a systematic reviewSilvio Matsas, Anderson Ruiz Simões, Luiza Giuliani Schmitt, et al.
Pageof 5